News
Hims and Hers stock rally looms with bullish EMAs, Novo Nordisk partnership, ZAVA acquisition, and new product launches ...
Discover why Hims & Hers is leading the telehealth market with strong growth, a loyal user base, and expansion into new ...
4d
Zacks Investment Research on MSNHims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on ItHims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...
7d
24/7 Wall St. on MSNBought $40,000 of Hims & Hers (HIMS) Stock on a YOLO – Is it Time to Sell?Key Points Hims & Hers is an exciting stock in the telehealth sector, but as a growth stock, it’s not for the faint of heart.
Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today ...
Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...
This fast growth has created some high expectations for Hims & Hers stock. It now has a price-to-earnings ratio (P/E) of 79, ...
Hims & Hers is acquiring digital health provider ZAVA to expand into Europe, aiming to boost revenue and international market ...
Dutch, a telehealth startup by Hims co-founder Joe Spector, uses AI to cut vet burnout, expand access, and make pet care more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results